Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by MetzGERon Sep 08, 2022 2:01am
69 Views
Post# 34948603

RE:RE:Brokered Private Placement

RE:RE:Brokered Private PlacementIt is always a Big Mystery For me When i hear about "the company Go pur of working Capital" they Receive every Year 500.000$-1.000.000$ pit of Private Placements. And what is exactly the "working Capital" For? They don't work they just take a loan For existing. It is Not like a real company who Needs Money to produce something. The Dermal injector is Ready and is tested and Tested and tested and tested and announced and apllied and tested. Theresienwiese Maybe you Need some money But of they Spend 1.000.000$ on Testing Each Year they are Little B4st4ards. Ok they Need a lawyer formshiseido arbitrstion But this isnt that expensive that they have to do a private Placement 2 Times every year.

the real thing is that Lee wants his salary of 300.000$ And he isnt Open to renounce on some salary like all shareholders Are renouncing about yield since Years and Are so f0cking Deep in minus.

F4CK LEE
<< Previous
Bullboard Posts
Next >>